$16.86
-0.47-2.71%
Ult. Agg.: Oct 23, 4:11 PM
Aurinia Pharmaceuticals (AUPH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Aurinia Pharmaceuticals (AUPH) ha pubblicato l'ultima guidance il agosto 6, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $315M - $325M per il periodo.
Rispetto alle previsioni precedenti, Aurinia Pharmaceuticals ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Aurinia Pharmaceuticals ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Aurinia Pharmaceuticals. 14
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.24 | $0.19 | $0.21 | $0.16 |
| Actual | $0.28 | $0.25 | $0.26 | $0.23 |
| Surprise | +16.7% | +31.6% | +23.8% | +43.8% |
| Revenue | ||||
| Estimate | $80.8M | $77.1M | $74.6M | $68.0M |
| Actual | $83.2M | $77.7M | $77.1M | $73.5M |
| Surprise | +2.97% | +0.83% | +3.40% | +8.03% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.22 | $0.20 |
| Revenue | ||
| Consensus | $84.3M | $86.2M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.28 | $0.24 | 16.7 % |
| Q1 | May 7, 2026 | $0.25 | $0.19 | 31.6 % |
| Q4 | Feb 26, 2026 | $0.26 | $0.21 | 23.8 % |
| Q3 | Nov 4, 2025 | $0.23 | $0.16 | 43.8 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $83.22M | $80.82M | 2.97 % |
| Q1 | May 7, 2026 | $77.71M | $77.06M | 0.83 % |
| Q4 | Feb 26, 2026 | $77.11M | $74.58M | 3.40 % |
| Q3 | Nov 4, 2025 | $73.47M | $68.01M | 8.03 % |